Companies

Cradle

cradle.bio

AI-powered platform to design and optimize proteins with privacy-preserving IP ownership.

HQAmsterdam, The Netherlands
Employees51-200
Funding$103M
Valuation$9.35M
6 active roles
AI / MLFoundation Model ProviderB2B SaaSSeries A$50M-$200M

About

Cradle Bio offers an AI-powered platform that designs and optimizes proteins using predictive algorithms and AI design suggestions. The platform enables researchers to generate and validate protein candidates, optimize across multiple properties (binding, activity, stability, expression), and manage data with user ownership of sequences and data. Target customers include pharma, industrial biotech, and food-tech research organizations; revenue comes from a software platform subscription and related services, with a privacy-first, SOC 2-compliant approach.

Active Roles

6
Zürich/Design/10d ago
Amsterdam/Other/98d ago
Europe (Remote)/Professional Services/151d ago
Boston/Professional Services/151d ago
Boston/Customer Success Manager/151d ago

Key Investors

Index Ventures, IVP, Kindred Capital